therapeutic candidate Applications
-
Microbiome Therapeutics for Patients and Physicians
Seres’ microbiome therapeutics represent a transformative new approach to ...
By Seres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Proteome array screening solutions for antibody specificity profiling sector
Comprehensive antibody reactivity profiling: validate specificity, identify cross-reactions. The issue of antibody cross-reactivity is one that has often been often overlooked or sidelined in the past, with typical antibody QC involving evidence of binding to the intended target, while neglecting potential cross-reactivity. In recent years, however, many examples have come to light where poor validation of antibodies has led to misleading or erroneous conclusions for assays in which they are used as reagents, due ...
By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.
-
Affilin - Precision Targeting Technology for Radio Conjugates
The long-standing, successful use of radio-theranostics in imaging and therapy is based on targeting radiolabeled molecules to tumors or other diseased tissues. Over 10,000 hospitals worldwide use radioisotopes for in-vivo diagnosis or treatment, reaching around 35 million patients each year. The ideal cancer imaging tool is a homogenous conjugate with a precisely defined payload-to-carrier ratio, showing specific tumor-targeting with minimal side-effects and fast ...
By Navigo Proteins GmbH based in Halle, GERMANY.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you